Essure is a procedure that involves the insetion of a hysteroscope — a miniaturized telescope — through the vagina in order to insert a metal device inside both fallopian tubes. It was becoming the standard of care for female sterilization. It has a small percentage of surgical complications, and it was considered the best choice for today’s active women. Patients having an Essure procedure can return to work the next day after the surgery, and most times they do not require narcotics for postoperative pain (most only use 1 or 2 Motrin pills the day of the procedure). And, since the surgery is performed through the vagina, there are no scars. However, there have been some reports of women referring problems with pelvic pain and/or abnormal uterine bleeding after having this procedure done. The FDA has looked into this and required the manufacturer of the Essure to start a study to look if these reported symptoms are caused by the Essure or not. This study started in 2016 and should be completed by 2023.
On July 20, 2018, Bayer decided to remove Essure from the market by the end of this year.